MANAGING A NATIONAL CANCER CARE PROGRAM
MANAGING A NATIONAL CANCER CARE PROGRAM
The recent announcement that the government
has earmarked P3 billion for cancer care and assistance is a step in the right
direction. However, several questions arise about how this program will be
managed and implemented effectively.
Who Will Lead the Implementation? The Department of Health (DOH) is the most likely
lead implementing agency, but will it work alone, or will the Department of the
Interior and Local Government (DILG) also play a role in mobilizing local
government units (LGUs)? Given the scale of the initiative, coordination among
various agencies is crucial to ensure effective nationwide implementation.
Funding Allocation and Coverage: A critical concern is how the P3 billion budget will
be distributed across different types of cancers. Will there be prioritization
based on mortality rates, prevalence, or cost of treatment? Additionally, will
the program cover outpatient care and medicines, or will funding be limited to
hospitalization? Many cancer patients struggle with the high costs of
outpatient chemotherapy and medications, and failing to include these aspects
could undermine the program’s effectiveness.
Interaction with Existing Programs: The Philippine
Charity Sweepstakes Office (PCSO) and PhilHealth already provide some
cancer-related financial assistance. Will the new program complement these
existing efforts, or will there be potential overlaps and conflicts? Ensuring a
streamlined approach is key to maximizing resources and avoiding bureaucratic
delays that hinder patient access.
International Models and Readiness: Is the new
cancer care initiative modeled after successful programs in other countries,
such as Australia, the United States, or South Korea? If so, which elements
have been adapted for the Philippine healthcare system? Furthermore, was the
announcement based on a fully developed implementation plan, or is the
government still drafting the necessary rules and regulations? A common issue
in healthcare legislation is the delay in finalizing Implementing Rules and
Regulations (IRRs), which could stall the program’s rollout.
Involvement of Key Stakeholders: Was the Philippine Cancer Society or other medical
associations consulted before the law was passed? Their input is crucial in
shaping a practical and effective program. Additionally, if approximately
35,040 Filipinos die from cancer annually, how many lives does the government
project will be saved through this initiative? If 194 cancer cases are
diagnosed per 100,000 patients today, how will this number change under the new
program?
National Cancer Database and
Accessibility: A robust cancer patient database is essential for
tracking cases, monitoring treatment outcomes, and ensuring equitable access.
Does the new law provide for such a database, and if so, how will it be
maintained? More importantly, how can we guarantee that even the poorest
patients benefit from cancer care and medication support?
Long-Term Vision and Infrastructure: Does the
program offer long-term care beyond initial consultations? Will government
hospitals be upgraded to provide specialized cancer treatments? Addressing these
concerns is essential if the country aims to achieve a cancer-free status in
the future.
Human Resource Challenges: The Philippines
faces a shortage of oncologists, with only around 112 radiation oncologists
serving the entire country. Given the demand, was this law passed with a plan
to increase the number of trained oncologists? Will there be incentives for
general practitioners to specialize in oncology? Furthermore, does the law
include provisions for a dedicated national cancer hospital, like the
Philippine Heart Center (PHC) or the National Kidney and Transplant Institute
(NKTI)?
These questions demand urgent answers. While
the allocation of P3 billion is commendable, it must be backed by a concrete,
well-structured implementation plan. Otherwise, this much-needed initiative
risks falling into the common pitfalls of underfunded, poorly executed
government programs. Cancer patients in the Philippines deserve better—and the
success of this program will be measured not just in pesos spent, but in lives
saved.
Ramon Ike V. Seneres,
www.facebook.com/ike.seneres
iseneres@yahoo.com, 09088877282, senseneres.blogspot.com
03-03-2025
Comments
Post a Comment